Zeincro has joined forces with Excelya to provide comprehensive services across Europe that will best serve our customers’ needs. Together, we have become The Excelya Group.

News & Events
Send to a friend
Senior Appointment in Safety and Pharmacovigilance

ZEINCRO, a specialist provider of clinical research services, announces the appointment of Veselin Ivanchev as ZEINCRO Head of Safety Department.

Veselin has an over 20 years experience in healthcare and the CRO industries having held  senior positions in international CROs and Pharma companies in the area of Safety and Pharmacovigilance. A graduate in Biotechnology with an MBA from The City University of Seattle, over the last 4 years, Veselin held the position of Associate Director for a global CRO during which he managed to grow his team from a total of 7 to a total of 67 professionals, expanding at the same time its client base across many countries in EU and the US. Prior to this, Veselin was for over 5 years Regulatory Affairs and Safety Manager for a Multinational Pharma company, while before he held other positions with healthcare companies and CROs. In addition to his Safety and PV experience, Veselin brings to ZEINCRO significant therapeutic expertise in areas such as Endocrinology, Infectious Diseases, Circulatory, CNS, Opthalmology, Dermatology and other.


“We are happy to welcome Ves to our team and we are confident that his skills, energy and leadership will enable us to further expand our Safety Department international activities as well as our Safety Services offering, in order to encompass the whole life cycle of a drug, but also expand in other demanding areas such as this of Medical Devices and Cosmetics. Ves will play an instrumental role in establishing ZEINCRO as the leading regional CRO also in the Safety Services area” commented Prof. Gregory Sivolapenko, Director of ZEINCRO.


ZEINCRO delivers bespoke clinical research services that are flexible and ethical, maximising patient recruitment and compliance. In addition to clinical research services, ZEINCRO provides services in the areas of post-marketing safety and efficacy studies, regulatory affairs and pharmacovigilance including risk management plans.





ZEINCRO is a leading Contract Research Organization  (CRO) covering 14 countries in Central- and South-Eastern Europe (Bulgaria, Cyprus, Czech Republic, Estonia, F.Y.R. of Macedonia, Greece, Hungary, Latvia, Lithuania, Moldova, Poland, Romania, Slovakia and Turkey).


With fifteen years of experience in successful clinical research projects in the region, ZEINCRO has developed a thorough understanding of the communities and the regions in which it operates and has established strong professional links with local healthcare stakeholders. This approach allows ZEINCRO to set new standards for successful clinical trials by delivering bespoke services that are flexible, ethical and maximise patient recruitment and compliance. ZEINCRO manages to balance productivity and quality incorporating added value techniques based on each country’s local knowledge.


ZEINCRO provides clinical trial services to the global drug development industry and offers additional services in post-marketing safety and efficacy studies, regulatory affairs and pharmacovigilance including risk management plans.


For more information, visit www.zeincro.com


ZEINCRO is a leading contract research organization covering more than 21 countries in Europe, with a special focus in the region of Central and South Eastern Europe (Albania, Austria, Bulgaria, Cyprus, Czech Republic, Germany, Estonia, FYROM, Greece, Hungary, Latvia, Lithuania, Malta, Moldova, the Netherlands, Poland, Romania, Slovakia, Switzerland, Turkey and Ukraine).

Read more


  • Email:  info@zeincro.com

ZEINCRO : member of

European CRO Federation (EUCROF)

© 2012-2021 ZEINCRO Group - All rights reserved.
Developed by LogicONE